Boeing Down 10.6% in a Month: Is This an Indication to Sell the Stock?

Boeing shares fell 10.6% over the past month, and the article advises avoiding the stock, citing $45.9 billion in debt, $2.78 billion of aircraft cancellations in the six months ended June 30, 2026, and a 777X program seven years behind schedule. Boeing expects $1 billion-$3 billion in free cash flow in 2026, while a $700 million DOJ payment is scheduled for Q3. Offsetting risks, seven-year PAC-3 MSE work enables Boeing to triple seeker production, and a new order for four MH-139A helicopters brings the program total to 42 contracted; Boeing’s forward P/S is 1.36X versus the industry’s 2.11X, but ROIC is negative and it has a Zacks Rank #4 (Sell).

Analysis

The key distinction is between order visibility and cash conversion. The defense awards improve utilization visibility, but they do not yet demonstrate that Boeing can convert production growth into cash or repair returns on capital; the PAC-3 work also supports Lockheed Martin’s program, so it is not a clean competitive win over LMT. The commercial-aircraft execution problem remains the larger equity driver: a low sales multiple can persist if delivery reliability, program costs, and cash generation remain uncertain. Forecast EPS growth is especially weak evidence for a rerating unless it is accompanied by sustained free-cash-flow delivery and debt reduction.

Near term, the contract news is unlikely to outweigh already-known execution concerns. Over 1–3 months, monitor commercial production/deliveries, net orders after cancellations, and cash conversion; over 6–18 months, the decisive question is whether 777X delays or further cost growth consume the balance-sheet improvement. A downside surprise to cash generation could tighten financial flexibility even without a new demand shock. Conversely, sustained delivery recovery and credible debt paydown would invalidate the underweight thesis. The article’s discount-to-sales comparison is not sufficient to establish cheapness without evidence of improving margins and ROIC.

Key Decisions for Investors

• Prefer a measured, dollar-neutral pair: underweight BA against a basket of LMT and NOC rather than make a large outright short. The thesis is relative execution and cash-conversion risk, not a forecast of collapsing aircraft demand; the defense names also carry sector risk.
• Avoid adding to BA solely on the defense awards or projected EPS rebound. Reassess after the next operating update: require evidence of improving commercial deliveries and free cash flow, alongside continued debt reduction, before increasing exposure.
• Watch for falsification: sustained production and delivery improvement, fewer net cancellations, and free cash flow tracking toward or above management’s 2026 range would justify covering the relative underweight. Further 777X slippage, weaker cash conversion, or a lower cash-flow outlook would strengthen it.
• Verify the scale and economics of the PAC-3 and MH-139A work before attributing material consolidated earnings impact; contract visibility alone does not establish incremental margins or near-term cash contribution.